The buccal administration of a NanoCelle Cannabidiol formulation to healthy volunteers: a pharmacokinetic, safety and tolerability exploratory pilot study
Not yet recruiting
Phase of Trial: Phase 0
Latest Information Update: 19 Nov 2018
At a glance
- Drugs Cannabidiol (Primary) ; Propylene glycol
- Indications Pain
- Focus Adverse reactions
- Sponsors Medlab
- 08 Nov 2018 Planned initiation date changed from 15 Nov 2018 to 10 Jan 2019.
- 23 Aug 2018 Planned initiation date changed from 1 Feb 2018 to 15 Nov 2018.
- 27 Oct 2017 New trial record